Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Angiography | Research article

Assessment of choriocapillary blood flow changes in response to half-dose photodynamic therapy in chronic central serous chorioretinopathy using optical coherence tomography angiography

Authors: Juejun Liu, Changzheng Chen, Lu Li, Yishuang Xu, Zuohuizi Yi, Lu He, Hongmei Zheng

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Optical coherence tomography angiography (OCTA) is a newly developed imaging quantitative technique for analysis of choriocapillaris (CC) flow changes, thereby exploring the pathological mechanism of chronic central serous chorioretinopathy (CCSC) and the therapeutic effects of photodynamic therapy (PDT). In this study, we sought to quantify the blood flow changes in CC of CCSC patients receiving half-dose PDT using OCTA.

Methods

A total of 28 affected eyes and 24 unaffected eyes of 26 CCSC patients receiving half-dose PDT, and 40 eyes of 20 healthy gender- and age-matched subjects were retrospectively enrolled in this study. The proportion of total areas of flow signal voids (FSV, %) in CC level of OCTA was assessed in both eyes of the CCSC patients at baseline and repeated in multiple sections at 1-week, 1-month, 3-month and 6-month intervals after PDT. In addition, the CC patterns in response to PDT at early stage and the subsequent morphologic changes were qualitatively documented using OCTA.

Results

For affected eyes, FSV at 6-m follow-up was significantly lower than that at 1-m follow-up (p = 0.036). When compared to normal control eyes, FSV in affected eyes was significantly higher at 1-m, 3-m and 6-m follow-up (p < 0.05 for all), and FSV in unaffected eyes was significantly higher at baseline, 1-w, 1-m and 3-m follow-up (p < 0.05 for all). Three CC patterns of early response to PDT were identified, including signs of recovery with more even flow signals, transient appearance of worse ischemia and secondary neovascularization within CC level.

Conclusion

Abnormal CC flow attenuation remains in completely resolved eyes of CCSC patients treated with half-dose PDT.
Literature
1.
go back to reference Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82–118.CrossRef Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82–118.CrossRef
2.
go back to reference Gal-Or O, Dansingani KK, Sebrow D, Dolz-Marco R, Freund KB. Inner Choroidal Flow Signal Attenuation in Pachychoroid Disease: optical coherence tomography angiography. Retina. 2018;38(10):1984–92.CrossRef Gal-Or O, Dansingani KK, Sebrow D, Dolz-Marco R, Freund KB. Inner Choroidal Flow Signal Attenuation in Pachychoroid Disease: optical coherence tomography angiography. Retina. 2018;38(10):1984–92.CrossRef
3.
go back to reference Wei X, Sonoda S, Mishra C, et al. Comparison of Choroidal vascularity markers on optical coherence tomography using two-image Binarization techniques. Invest Ophth Vis Sci. 2018;59(3):1206–11..CrossRef Wei X, Sonoda S, Mishra C, et al. Comparison of Choroidal vascularity markers on optical coherence tomography using two-image Binarization techniques. Invest Ophth Vis Sci. 2018;59(3):1206–11..CrossRef
4.
go back to reference Lai FH, Ng DS, Bakthavatsalam M, et al. A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous Chorioretinopathy. Am J Ophthalmol. 2016;170:91–9.CrossRef Lai FH, Ng DS, Bakthavatsalam M, et al. A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous Chorioretinopathy. Am J Ophthalmol. 2016;170:91–9.CrossRef
5.
go back to reference Schmidt-Erfurth U, Laqua H, Schlotzer-Schrehard U, Viestenz A, Naumann GO. Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol. 2002;120(6):835–44.PubMed Schmidt-Erfurth U, Laqua H, Schlotzer-Schrehard U, Viestenz A, Naumann GO. Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol. 2002;120(6):835–44.PubMed
6.
go back to reference Borrelli E, Sarraf D, Freund KB, Sadda SR. OCT angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res. 2018;67:30–55.CrossRef Borrelli E, Sarraf D, Freund KB, Sadda SR. OCT angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res. 2018;67:30–55.CrossRef
7.
go back to reference Lauermann JL, Eter N, Alten F. Optical coherence tomography angiography offers new insights into Choriocapillaris perfusion. Ophthalmologica. 2018;239(2–3):74–84.CrossRef Lauermann JL, Eter N, Alten F. Optical coherence tomography angiography offers new insights into Choriocapillaris perfusion. Ophthalmologica. 2018;239(2–3):74–84.CrossRef
8.
go back to reference Spaide RF. Choriocapillaris flow features follow a power law distribution: implications for characterization and mechanisms of disease progression. Am J Ophthalmol. 2016;170:58–67.CrossRef Spaide RF. Choriocapillaris flow features follow a power law distribution: implications for characterization and mechanisms of disease progression. Am J Ophthalmol. 2016;170:58–67.CrossRef
9.
go back to reference Teussink MM, Breukink MB, Grinsven MJ, Hoyng CB, Klevering BJ. OCT angiography compared to fluorescein and indocyanine green ngiography in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2015;56(9):5229–37.CrossRef Teussink MM, Breukink MB, Grinsven MJ, Hoyng CB, Klevering BJ. OCT angiography compared to fluorescein and indocyanine green ngiography in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2015;56(9):5229–37.CrossRef
10.
go back to reference Quaranta-El Maftouhi M, El Maftouhi A, Eandi CM. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol. 2015;160(3):581–7 e581.CrossRef Quaranta-El Maftouhi M, El Maftouhi A, Eandi CM. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography. Am J Ophthalmol. 2015;160(3):581–7 e581.CrossRef
11.
go back to reference Rochepeau C, Kodjikian L, Garcia MA, et al. Optical coherence tomography angiography quantitative assessment of Choriocapillaris blood flow in central serous Chorioretinopathy. Am J Ophthalmol. 2018;194:26–34.CrossRef Rochepeau C, Kodjikian L, Garcia MA, et al. Optical coherence tomography angiography quantitative assessment of Choriocapillaris blood flow in central serous Chorioretinopathy. Am J Ophthalmol. 2018;194:26–34.CrossRef
12.
go back to reference Ogawa Y, Maruko I, Koizumi H, Iida T. Quantification of Choroidal Vasculature by High-Quality Structure En Face Swept-Source Optical Coherence Tomography Images in Eyes with Central Serous Chorioretinopathy. Retina. 2018;40(3):529–36. Ogawa Y, Maruko I, Koizumi H, Iida T. Quantification of Choroidal Vasculature by High-Quality Structure En Face Swept-Source Optical Coherence Tomography Images in Eyes with Central Serous Chorioretinopathy. Retina. 2018;40(3):529–36.
13.
go back to reference Xu Y, Su Y, Li L, Qi H, Zheng H, Chen C. Effect of photodynamic therapy on optical coherence tomography angiography in eyes with chronic central serous Chorioretinopathy. Ophthalmologica. 2017;237(3):167–72.CrossRef Xu Y, Su Y, Li L, Qi H, Zheng H, Chen C. Effect of photodynamic therapy on optical coherence tomography angiography in eyes with chronic central serous Chorioretinopathy. Ophthalmologica. 2017;237(3):167–72.CrossRef
14.
15.
go back to reference Kraus MF, Liu JJ, Schottenhamml J, et al. Quantitative 3D-OCT motion correction with tilt and illumination correction, robust similarity measure and regularization. Biomed Opt Express. 2014;5(8):2591–613.CrossRef Kraus MF, Liu JJ, Schottenhamml J, et al. Quantitative 3D-OCT motion correction with tilt and illumination correction, robust similarity measure and regularization. Biomed Opt Express. 2014;5(8):2591–613.CrossRef
16.
go back to reference Demircan A, Yesilkaya C, Alkin Z. Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: preliminary results. Photodiagn Photodyn Ther. 2018;21:375–8.CrossRef Demircan A, Yesilkaya C, Alkin Z. Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: preliminary results. Photodiagn Photodyn Ther. 2018;21:375–8.CrossRef
17.
go back to reference Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina. 2010;30(5):801–9.CrossRef Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina. 2010;30(5):801–9.CrossRef
18.
go back to reference Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina. 1999;19(6):508–12.CrossRef Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina. 1999;19(6):508–12.CrossRef
19.
go back to reference Nicolo M, Rosa R, Musetti D, Musolino M, Saccheggiani M, Traverso CE. Choroidal vascular flow area in central serous Chorioretinopathy using swept-source optical coherence tomography angiography. Invest Ophth Vis Sci. 2017;58(4):2002–10.CrossRef Nicolo M, Rosa R, Musetti D, Musolino M, Saccheggiani M, Traverso CE. Choroidal vascular flow area in central serous Chorioretinopathy using swept-source optical coherence tomography angiography. Invest Ophth Vis Sci. 2017;58(4):2002–10.CrossRef
21.
go back to reference Kang NH, Kim YT. Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy. Eye (Lond). 2013;27(3):387–91.CrossRef Kang NH, Kim YT. Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy. Eye (Lond). 2013;27(3):387–91.CrossRef
22.
go back to reference Park S, Kim B, Park K, Woo S. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy. Am J Ophthalmol. 2014;158(6):1155–63.CrossRef Park S, Kim B, Park K, Woo S. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy. Am J Ophthalmol. 2014;158(6):1155–63.CrossRef
23.
go back to reference Schmidt-Erfurth U, Kiss C, Sacu S. The role of choroidal hypoperfusion associated with photodynamic therapy in neovascular age-related macular degeneration and the consequences for combination strategies. Prog Retin Eye Res. 2009;28(2):145–54.CrossRef Schmidt-Erfurth U, Kiss C, Sacu S. The role of choroidal hypoperfusion associated with photodynamic therapy in neovascular age-related macular degeneration and the consequences for combination strategies. Prog Retin Eye Res. 2009;28(2):145–54.CrossRef
24.
go back to reference Chhablani J, Pichi F, Silva R, et al. Antiangiogenics in Choroidal neovascularization associated with laser in central serous Chorioretinopathy. Retina. 2016;36(5):901–8.CrossRef Chhablani J, Pichi F, Silva R, et al. Antiangiogenics in Choroidal neovascularization associated with laser in central serous Chorioretinopathy. Retina. 2016;36(5):901–8.CrossRef
25.
go back to reference Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2003;44(10):4473–80.CrossRef Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2003;44(10):4473–80.CrossRef
26.
go back to reference Schlotzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol. 2002;240(9):748–57.CrossRef Schlotzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol. 2002;240(9):748–57.CrossRef
27.
go back to reference Moussa M, Leila M, Khalid H, Lolah M. Detection of Silent Type I Choroidal Neovascular Membrane in Chronic Central Serous Chorioretinopathy Using En Face Swept-Source Optical Coherence Tomography Angiography. J Ophthalmol. 2017;2017:6913980. https://doi.org/10.1155/2017/6913980. Moussa M, Leila M, Khalid H, Lolah M. Detection of Silent Type I Choroidal Neovascular Membrane in Chronic Central Serous Chorioretinopathy Using En Face Swept-Source Optical Coherence Tomography Angiography. J Ophthalmol. 2017;2017:6913980. https://​doi.​org/​10.​1155/​2017/​6913980.
28.
go back to reference Spaide RF. Optical coherence tomography angiography signs of vascular Abnormalization with Antiangiogenic therapy for Choroidal neovascularization. Am J Ophthalmol. 2015;160(1):6–16.CrossRef Spaide RF. Optical coherence tomography angiography signs of vascular Abnormalization with Antiangiogenic therapy for Choroidal neovascularization. Am J Ophthalmol. 2015;160(1):6–16.CrossRef
29.
go back to reference Shiragami C, Takasago Y, Osaka R, et al. Clinical features of central serous Chorioretinopathy with type 1 Choroidal neovascularization. Am J Ophthalmol. 2018;193:80–6.CrossRef Shiragami C, Takasago Y, Osaka R, et al. Clinical features of central serous Chorioretinopathy with type 1 Choroidal neovascularization. Am J Ophthalmol. 2018;193:80–6.CrossRef
30.
go back to reference Wu JS, Chen SN. Optical coherence tomography angiography for diagnosis of Choroidal neovascularization in chronic central serous Chorioretinopathy after photodynamic therapy. Sci Rep. 2019;9(1):9040.CrossRef Wu JS, Chen SN. Optical coherence tomography angiography for diagnosis of Choroidal neovascularization in chronic central serous Chorioretinopathy after photodynamic therapy. Sci Rep. 2019;9(1):9040.CrossRef
31.
go back to reference Yun C, Huh J, Ahn SM, et al. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):57–70.CrossRef Yun C, Huh J, Ahn SM, et al. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):57–70.CrossRef
Metadata
Title
Assessment of choriocapillary blood flow changes in response to half-dose photodynamic therapy in chronic central serous chorioretinopathy using optical coherence tomography angiography
Authors
Juejun Liu
Changzheng Chen
Lu Li
Yishuang Xu
Zuohuizi Yi
Lu He
Hongmei Zheng
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01674-9

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue